14-day Premium Trial Subscription Try For FreeTry Free
$1.63
+0.150 (+10.14%)
At Close: May 03, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

54 Biggest Movers From Friday

 12:00am, Monday, 08'th Apr 2019

58 Biggest Movers From Yesterday

 12:00am, Tuesday, 02'nd Apr 2019

46 Stocks Moving In Monday's Mid-Day Session

 12:00am, Monday, 01'st Apr 2019

CEL-SCI Highlights Recent Data Review By Independent Data Monitoring Committee for Its Pivotal Phase 3 Head and Neck Cancer Study: Recommended Continue Trial Until Appropriate Number Of Events Have Occurred

 12:00am, Friday, 29'th Mar 2019

CEL-SCI Announces Extension of its Phase 3 Trial in a Letter to Shareholders

 12:00am, Monday, 25'th Mar 2019

CEL-SCI'S Phase III Trial In Head & Neck Cancer My Analysis

 12:00am, Tuesday, 19'th Mar 2019

CEL-SCI Selected By National Institutes of Health To Showcase Its LEAPS Technology At BIO International Convention

 12:00am, Thursday, 07'th Mar 2019

CEL-SCI Q1 EPS $0.02 Up From $(0.53) YoY, Sales $126.41K Up From $113.897K YoY

 12:00am, Thursday, 14'th Feb 2019

CEL-SCI (CVM) Presents At BIO CEO & Investor Conference - Slideshow

 12:00am, Tuesday, 12'th Feb 2019

CEL-SCI Shares Spike To Session High; Traders Circulating Word Zacks Initiated Stock With A Buy Rating And $14 Price Target; BZ NOTE: Zacks Research Does Not Normally Move Stocks

 12:00am, Thursday, 31'st Jan 2019

Cel-Sci And Multikine Immunotherapy In Head And Neck Cancer: High Risk With Great Reward

 12:00am, Friday, 25'th Jan 2019

CEL-SCI nabs two U.S. patents on platform technology

 12:00am, Wednesday, 23'rd Jan 2019

55 Biggest Movers From Yesterday

 12:00am, Wednesday, 16'th Jan 2019

CEL-SCI Reports Regained Full Compliance With NYSE American

 12:00am, Tuesday, 15'th Jan 2019

CEL-SCI FY18 EPS $(1.87) vs $(1.91) In FY17

 12:00am, Thursday, 20'th Dec 2018
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE